summary
Introduced
03/12/2026
03/12/2026
In Committee
03/12/2026
03/12/2026
Crossed Over
Passed
Dead
Introduced Session
119th Congress
Bill Summary
A BILL To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
AI Summary
This bill, titled the Safeguarding Women from Chemical Abortion Act, proposes to effectively withdraw the approval of the drug mifepristone, also known as RU-486, for the purpose of terminating pregnancies under the Federal Food, Drug, and Cosmetic Act, making its introduction into commerce a violation and its labeling for such use considered misbranded. Additionally, it establishes a federal legal claim, or "tort," allowing individuals who suffer physical or mental harm from using mifepristone to sue the manufacturer for damages, including compensatory, punitive, and legal costs, without preventing states from offering additional remedies.
Committee Categories
Business and Industry
Sponsors (9)
Diana Harshbarger (R)*,
Mark Alford (R),
Sheri Biggs (R),
Neal Dunn (R),
Tracey Mann (R),
Mary Miller (R),
John Rose (R),
Chris Smith (R),
Greg Steube (R),
Last Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 03/12/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/119th-congress/house-bill/7902/all-info |
| BillText | https://www.congress.gov/119/bills/hr7902/BILLS-119hr7902ih.pdf |
Loading...